Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	100
Overall Study	STARTED	Irsenontrine 50 mg	100
Overall Study	STARTED	Randomised, Not Treated Due to Site Closure	6
Overall Study	Treated	Placebo	97
Overall Study	Treated	Irsenontrine 50 mg	99
Overall Study	Treated	Randomised, Not Treated Due to Site Closure	0
Overall Study	COMPLETED	Placebo	84
Overall Study	COMPLETED	Irsenontrine 50 mg	89
Overall Study	COMPLETED	Randomised, Not Treated Due to Site Closure	0
Overall Study	NOT COMPLETED	Placebo	16
Overall Study	NOT COMPLETED	Irsenontrine 50 mg	11
Overall Study	NOT COMPLETED	Randomised, Not Treated Due to Site Closure	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03467152/flow